FDABridge
← Balik sa blog
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

FDA Stories #007 — A Mexican Hot Sauce Maker Needed an FCE Number They Had Never Heard Of

Bidhaa ishirini na mbili za vipodozi zilisajiliwa chini ya MoCRA bila matatizo. Ya ishirini na tatu ilikuwa na rangi inayoruhusiwa Korea lakini imepigwa marufuku Marekani.

Koponan ng FDABridge•Ene 1, 2026•3 min na mabasa

A K-beauty brand based in Seoul had 23 skincare and makeup products ready for the US market. They came to us for MoCRA facility registration and product listing. We registered the facility, designated ourselves as US Agent, and began listing each product — reviewing ingredient lists, verifying INCI names, checking for prohibited or restricted substances.

Products 1 through 22 passed review without issue. Product 23 — a popular lip tint — did not.

Tatizo

The lip tint contained CI 15510, also known as D&C Orange No. 4. In South Korea, this colorant is approved for use in lip products. In the United States, D&C Orange No. 4 is approved for external use only — it cannot be used in products applied to the lips or in any area where it may be ingested. Under 21 CFR 74.1254, the colorant is restricted to externally applied cosmetics. A lip tint is not externally applied — it is applied to the lips, which is a mucous membrane area.

If the lip tint had been imported into the US and sold with this colorant, it would have been adulterated under the FD&C Act. Import Alert 53-04 specifically targets cosmetics containing unauthorized color additives. A single adulterated product in a shipment can trigger FDA scrutiny of the entire brand.

Tulifanya nini

We flagged the ingredient during pre-listing review and notified the brand immediately. They had two options: reformulate the lip tint with a color additive approved for lip use in the US (such as D&C Red No. 6 or D&C Red No. 7), or exclude the product from the US market entirely. They chose to reformulate. The new formulation took six weeks. We listed the product with the FDA once the reformulated version was ready.

The other 22 products entered the US market on schedule. The lip tint followed six weeks later with a compliant formula.

Somo

Color additive regulations in the US are completely different from Korea, the EU, and Japan. A colorant that is approved in your home market may be prohibited, restricted, or require batch certification in the United States. This is not something you discover at the border — it is something you check before you formulate for the US market. Send us your ingredient lists at fdabridge.com/cosmetics.

Kailangan mo ng tulong sa susunod?

Kailangan ng tulong sa pagpili ng serbisyo?

Ihambing ang mga serbisyo at piliin ang tamang filing path para sa iyong produkto.

Mas marami pang mabasa

Mga kaugnay na artikulo

Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Alama za Uwekaji Lebo wa Kifaa cha Matibabu: Watengenezaji wa Kigeni Lazima Wajue Nini kwa Kuingia Soko la Marekani

Abr 28, 2026

Uwekaji lebo wa kifaa cha matibabu nchini Marekani unahitaji alama maalum kwa mawasiliano sahihi. Watengenezaji wa kigeni lazima waelewe viwango vya alama vinavyokubalika na FDA kabla ya kusafirisha vifaa kwenda soko la Marekani.

Magbasa pa →
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Usajili wa vifaa vya matibabu kwa watengenezaji wa kigeni: Mwongozo wa Mfumo wa Udhibiti wa Marekani

Mar 26, 2026

Watengenezaji wa vifaa vya matibabu wa kigeni lazima waandikishe taasisi zao, orodha ya vifaa vyao, na kulingana na darasa la vifaa kupata idhini ya FDA au idhini kabla ya kusambaza nchini Marekani.

Magbasa pa →
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Maswali Kumi ya Kujiuliza Kabla ya Kuajiri Mshauri wa FDA

May 24, 2026

Kuchagua mtoa huduma wa kufuata sheria za FDA ni uamuzi muhimu. Maswali hayo kumi huwasaidia wazalishaji wa kigeni kuwatenganisha washauri wenye uwezo na wale watakaotokeza matatizo ambayo hawawezi kuyatatua.

Magbasa pa →